CORRECTION: Biotricity Q4 EPS $(0.09) Up From $(0.11) YoY, Sales $2.74M Miss $3.16M Estimate
Portfolio Pulse from Benzinga Newsdesk
Biotricity (NASDAQ:BTCY) reported Q4 losses of $(0.09) per share, an 18.18% improvement from $(0.11) per share YoY. However, the company's quarterly sales of $2.74 million missed the analyst consensus estimate of $3.16 million by 13.29%, despite a 27.44% increase from $2.15 million YoY.
June 30, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Biotricity's Q4 results show improved losses but missed sales estimates. This mixed result could lead to uncertain market reactions.
Biotricity's Q4 results are mixed with improved losses but missed sales estimates. While the reduced losses are a positive sign, the missed sales estimates could be a concern for investors. This could lead to a neutral or uncertain market reaction in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100